- Home
- SRRK vs FFIN Comparison
SRRK vs FFIN Comparison
Compare SRRK & FFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SRRK | FFIN |
|---|---|---|
| Founded | 2012 | 1890 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.7B |
| IPO Year | 2018 | 1994 |
Fundamental Metrics
Financial Performance| Metric | SRRK | FFIN |
|---|---|---|
| Price | $44.36 | $33.54 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 2 |
| Target Price | ★ $56.17 | $36.50 |
| AVG Volume (30 Days) | ★ 1.0M | 746.9K |
| Earning Date | 05-07-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 2.39% |
| EPS Growth | N/A | ★ 13.46 |
| EPS | N/A | ★ 0.50 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $17.16 |
| Revenue Next Year | $534.24 | $6.61 |
| P/E Ratio | ★ N/A | $67.30 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.07 | $28.12 |
| 52 Week High | $52.19 | $38.74 |
Technical Indicators
Market Signals| Indicator | SRRK | FFIN |
|---|---|---|
| Relative Strength Index (RSI) | 41.50 | 63.53 |
| Support Level | $42.52 | $31.30 |
| Resistance Level | $48.23 | $34.79 |
| Average True Range (ATR) | 2.10 | 0.59 |
| MACD | -0.36 | 0.11 |
| Stochastic Oscillator | 14.24 | 92.56 |
Price Performance
Historical ComparisonAbout SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
About FFIN First Financial Bankshares Inc.
First Financial Bankshares Inc is a financial and bank holding company. The company operates one line of business (community banking) located in a single geographic area (Texas). The company conducts a full-service commercial banking business through its subsidiaries. The loan portfolio segments of the company include Commercial and Industrial, Municipal, Agricultural, Construction and Development, Farm, Non-Owner Occupied and Owner Occupied Commercial Real Estate, Residential, Consumer Auto and Consumer Non-Auto.